É. Lemarié - Concepedia

Author

É. Lemarié

Centre Hospitalier Universitaire de Tours

Also Known As

E Lemarie, E Lemarié, E, Lemarié, E. Lemarie, E. Lemarié, Lemarie E, Lemarie E., Lemarie, E., É. Lemarié

215

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Tours Hôpital Bretonneau Inserm Université de Tours Sorbonne Université

ÉL

About

É. Lemarié is an author at Centre Hospitalier Universitaire de Tours specializing in medicine, lung cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	1.1K
2	Health Sciences	7	7	360
3	Immunology	4	4	160
4	Allergy	2	2	130
5	Cell Biology	1	1	21

É. Lemarié

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung Cancer A Depierre, É. Lemarié, G Dabouis, American Journal of Clinical Oncology	1991	256
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial A Depierre, Claude Chastang, Élisabeth Quoix, Annals of Oncology OncologyMedicineBronchial NeoplasmRandomized TrialVinorelbine Versus Vinorelbine	1994	219
Etoposide Plus Cisplatin With or Without the Combination of 4'-Epidoxorubicin Plus Cyclophosphamide in Treatment of Extensive Small-Cell Lung Cancer: a French Federation of Cancer Institutes Multicenter Phase III Randomized Study Jean-Louis Pujol, Jean Pierre Daurès, Aart Brutel de la Rivière, JNCI Journal of the National Cancer Institute	2001	173
Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin Jean-Louis Pujol, Jean-Luc Breton, R. Gervais, Annals of Oncology Gemcitabine–docetaxel Versus Cisplatin–vinorelbineMedicineAnti-cancer AgentPhase Iii StudyCancer Treatment	2005	129
Systemic sclerosis and occupational risk factors: a case–control study Élisabeth Diot, V. Lesire, J.‐L. Guilmot, Occupational and Environmental Medicine	2002	121
Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system Laurent Guilleminault, Nicolas Azzopardi, Christophe Arnoult, Journal of Controlled Release AsthmaInhaled Monoclonal AntibodiesLung DepositionAllergyAerosolized Particles	2014	109
From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF) S. Couraud, Alexis B. Cortot, Laurent Greillier, Annals of Oncology	2012	102
A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients Jacek Jassem, Rodryg Ramlau, H Karnicka-Młodkowska, Annals of Oncology OncologyIntravenous VinorelbineMedicineMetronomic TherapyPhase Ii Study	2001	100
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer J. Rollin, Sophie Iochmann, Claire Bléchet, British Journal of Cancer	2005	75
Deposition of amphotericin B aerosols in pulmonary aspergilloma P. Diot, B Rivoire, A. Le Pape, European Respiratory Journal AsthmaLung DepositionPulmonary MycetomaRespiratory ToxicologyPharmacology	1995	58

Page 1